Robert Gregory Conway
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Robert Gregory Conway has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Bartley P. Griffith
Department of Surgery University of Maryland School of Medicine Baltimore MD USA
2 shared publicationsDouglas Tran
Department of Surgery University of Maryland School of Medicine Baltimore MD USA
2 shared publicationsJiafeng Zhang
Department of Surgery University of Maryland School of Medicine Baltimore MD USA
2 shared publicationsShahab Toursavadkohi
University of Maryland School of Medicine, Baltimore, Maryland
2 shared publications- Stephen M. Kavic
University of Maryland School of Medicine, Baltimore, MD, USA
2 shared publications - Zhongjun Jon Wu
Department of Surgery University of Maryland School of Medicine Baltimore Maryland USA
2 shared publications
Latest Publications
- 18 September 2024
- Published by Elsevier in Journal of Surgical Education
- Vol. 81 (11) , 1699-1708
Decreasing Resident Vascular Case Volumes Have Not Changed National Numbers of Vascular Fellowship Applications in US General Surgery Residents Over the Past Twenty Years
- 18 September 2024
- Published by Elsevier in Journal of Surgical Education
- Vol. 81 (11) , 1699-1708
Decreasing Resident Vascular Case Volumes Have Not Changed National Numbers of Vascular Fellowship Applications in US General Surgery Residents Over the Past Twenty Years
- Open Access
- 1 July 2020
- Published by Elsevier in Surgery Open Science
- Vol. 2 (3) , 113-116
An educated guess — Distance estimation by surgeons
- 1 July 2020
- Published by Elsevier in Surgery Open Science
- Vol. 2 (3) , 113-116
Open AccessAn educated guess — Distance estimation by surgeons
- 1 March 2020
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 8 (2) , 216-223
Clinical response to combination therapy in the treatment of varicose veins
- 1 March 2020
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 8 (2) , 216-223
Clinical response to combination therapy in the treatment of varicose veins
- 18 December 2019
- Published by Wiley in Artificial Organs
- Vol. 44 (5) , 478-487
Evaluation of an autoregulatory ECMO system for total respiratory support in an acute ovine model
Extracorporeal membrane oxygenation (ECMO) has become a mainstay of therapy for patients suffering from severe respiratory failure. Ambulatory ECMO systems aim to provide long‐term out‐of‐hospital respiratory support. As a patient’s activity level changes, the required level of ECMO support varies with oxygen consumption and metabolic fluctuations. To compensate for such changes, an autoregulatory ECMO system (AR‐ECMO) has been developed and its performance was evaluated as a proof of concept in an acute ovine model. The AR‐ECMO system consists of a regular ECMO circuit and an electromechanical control system. A custom fuzzy logic control algorithm was implemented to adjust the blood flow and sweep gas flow of the ECMO circuit to meet the varying respiratory demand by utilizing two noninvasive sensors for venous oxyhemoglobin saturation and the oxygenator exhaust gas CO2concentration. Disturbance responses of the AR‐ECMO to induced acute respiratory distress were assessed for six hours in four juvenile sheep cannulated with a veno‐pulmonary artery ECMO configuration, including acute ventilator shutoff, ventilator step change (off‐on‐off), and forced desaturation. All sheep survived for the study duration. The AR‐ECMO system was able to respond and maintain stable hemodynamics and physiological blood gas contents (SpO2 = 96.3 % ± 4.29, pH 7.44 ± 0.09, pCO2 = 38.9 ± 9.9 mm Hg, and pO2=237.9 ± 123.6 mm Hg) during simulated respiratory distress. Acceptable correlation between oxygenator exhaust gas CO2and oxygenator outlet pCO2were observed (R2 = 0.84). In summary, the AR‐ECMO system successfully maintained physiologic control of peripheral oxygenation and carbon dioxide over the study period, utilizing only measurements taken directly from the ECMO circuit. The range of system response necessitates an adaptable system in the setting of variable metabolic demands. The ability of this system to respond to significant disturbances in ventilator support is encouraging. Future work to evaluate our AR‐ECMO system in long‐term, awake animal studies is necessary for further refinement.
- 18 December 2019
- Published by Wiley in Artificial Organs
- Vol. 44 (5) , 478-487
Evaluation of an autoregulatory ECMO system for total respiratory support in an acute ovine model
Extracorporeal membrane oxygenation (ECMO) has become a mainstay of therapy for patients suffering from severe respiratory failure. Ambulatory ECMO systems aim to provide long‐term out‐of‐hospital respiratory support. As a patient’s activity level changes, the required level of ECMO support varies with oxygen consumption and metabolic fluctuations. To compensate for such changes, an autoregulatory ECMO system (AR‐ECMO) has been developed and its performance was evaluated as a proof of concept in an acute ovine model. The AR‐ECMO system consists of a regular ECMO circuit and an electromechanical control system. A custom fuzzy logic control algorithm was implemented to adjust the blood flow and sweep gas flow of the ECMO circuit to meet the varying respiratory demand by utilizing two noninvasive sensors for venous oxyhemoglobin saturation and the oxygenator exhaust gas CO2concentration. Disturbance responses of the AR‐ECMO to induced acute respiratory distress were assessed for six hours in four juvenile sheep cannulated with a veno‐pulmonary artery ECMO configuration, including acute ventilator shutoff, ventilator step change (off‐on‐off), and forced desaturation. All sheep survived for the study duration. The AR‐ECMO system was able to respond and maintain stable hemodynamics and physiological blood gas contents (SpO2 = 96.3 % ± 4.29, pH 7.44 ± 0.09, pCO2 = 38.9 ± 9.9 mm Hg, and pO2=237.9 ± 123.6 mm Hg) during simulated respiratory distress. Acceptable correlation between oxygenator exhaust gas CO2and oxygenator outlet pCO2were observed (R2 = 0.84). In summary, the AR‐ECMO system successfully maintained physiologic control of peripheral oxygenation and carbon dioxide over the study period, utilizing only measurements taken directly from the ECMO circuit. The range of system response necessitates an adaptable system in the setting of variable metabolic demands. The ability of this system to respond to significant disturbances in ventilator support is encouraging. Future work to evaluate our AR‐ECMO system in long‐term, awake animal studies is necessary for further refinement.
- 25 February 2019
- Published by Wiley in Artificial Organs
- Vol. 43 (8) , 745-755
Device‐induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding
Thrombotic and bleeding complications are the major obstacles for expanding mechanical circulatory support (MCS) beyond the current use. While providing the needed hemodynamic support, those devices can induce damage to blood, particularly to platelets. In this study, we investigated device‐induced alteration of three major platelet surface receptors, von Willebrand factor (VWF) and associated hemostatic functions relevant to thrombosis and bleeding. Fresh human whole blood was circulated in an extracorporeal circuit with a clinical rotary blood pump (CentriMag, Abbott, Chicago, IL, USA) under the clinically relevant operating condition for 4 hours. Blood samples were examined every hour for glycoprotein (GP) IIb/IIIa activation and receptor loss of GPVI and GPIbα on the platelet surface with flow cytometry. Soluble P‐selectin in hourly collected blood samples was measured by enzyme linked immunosorbent assay to characterize platelet activation. Adhesion of device‐injured platelets to fibrinogen, collagen, and VWF was quantified with fluorescent microscopy. Device‐induced damage to VWF was characterized with western blotting. The CentriMag blood pump induced progressive platelet activation with blood circulating time. Particularly, GPIIb/IIIa activation increased from 1.1% (Base) to 11% (4 hours) and soluble P‐selectin concentration increased from 14.1 ng/mL (Base) to 26.5 ng/mL (4 hours). Those device‐activated platelets exhibited increased adhesion capacity to fibrinogen. Concurrently, the CentriMag blood pump caused progressive platelet receptor loss (GPVI and GPIbα) with blood circulating time. Specifically, MFI of the GPVI and GPIbα receptors decreased by 17.2% and 16.1% for the 4‐hours sample compared to the baseline samples, respectively. The device‐injured platelets exhibited reduced adhesion capacities to collagen and VWF. The high molecular weight multimers (HMWM) of VWF in the blood disappeared within the first hour of the circulation. Thereafter the multimeric patterns of VWF were stable. The change in the VWF multimeric pattern was different from the progressive structural and functional changes of platelets with the circulation time. This study suggested that the CentriMag blood pump could induce two opposite effects on platelets and associated hemostatic functions under a clinically relevant operating condition. The device‐altered hemostatic function may contribute to thrombosis and bleeding simultaneously as occurring in patients supported by a rotary blood pump. Device‐induced damage of platelets may be an important cause for bleeding in patients supported with rotary blood pump MCS systems relative to device‐induced loss of HMWM‐VWF.
- 25 February 2019
- Published by Wiley in Artificial Organs
- Vol. 43 (8) , 745-755
Device‐induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding
Thrombotic and bleeding complications are the major obstacles for expanding mechanical circulatory support (MCS) beyond the current use. While providing the needed hemodynamic support, those devices can induce damage to blood, particularly to platelets. In this study, we investigated device‐induced alteration of three major platelet surface receptors, von Willebrand factor (VWF) and associated hemostatic functions relevant to thrombosis and bleeding. Fresh human whole blood was circulated in an extracorporeal circuit with a clinical rotary blood pump (CentriMag, Abbott, Chicago, IL, USA) under the clinically relevant operating condition for 4 hours. Blood samples were examined every hour for glycoprotein (GP) IIb/IIIa activation and receptor loss of GPVI and GPIbα on the platelet surface with flow cytometry. Soluble P‐selectin in hourly collected blood samples was measured by enzyme linked immunosorbent assay to characterize platelet activation. Adhesion of device‐injured platelets to fibrinogen, collagen, and VWF was quantified with fluorescent microscopy. Device‐induced damage to VWF was characterized with western blotting. The CentriMag blood pump induced progressive platelet activation with blood circulating time. Particularly, GPIIb/IIIa activation increased from 1.1% (Base) to 11% (4 hours) and soluble P‐selectin concentration increased from 14.1 ng/mL (Base) to 26.5 ng/mL (4 hours). Those device‐activated platelets exhibited increased adhesion capacity to fibrinogen. Concurrently, the CentriMag blood pump caused progressive platelet receptor loss (GPVI and GPIbα) with blood circulating time. Specifically, MFI of the GPVI and GPIbα receptors decreased by 17.2% and 16.1% for the 4‐hours sample compared to the baseline samples, respectively. The device‐injured platelets exhibited reduced adhesion capacities to collagen and VWF. The high molecular weight multimers (HMWM) of VWF in the blood disappeared within the first hour of the circulation. Thereafter the multimeric patterns of VWF were stable. The change in the VWF multimeric pattern was different from the progressive structural and functional changes of platelets with the circulation time. This study suggested that the CentriMag blood pump could induce two opposite effects on platelets and associated hemostatic functions under a clinically relevant operating condition. The device‐altered hemostatic function may contribute to thrombosis and bleeding simultaneously as occurring in patients supported by a rotary blood pump. Device‐induced damage of platelets may be an important cause for bleeding in patients supported with rotary blood pump MCS systems relative to device‐induced loss of HMWM‐VWF.
- 1 August 2016
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 64 (2) , 500-505
Evolution of lesion-specific management of blunt thoracic aortic injury
- 1 August 2016
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 64 (2) , 500-505
Evolution of lesion-specific management of blunt thoracic aortic injury
- 1 November 2015
- Published by Elsevier in Journal of Surgical Education
- Vol. 72 (6) , 1233-1239
Residents’ Experience in Breast Cancer Care
- 1 November 2015
- Published by Elsevier in Journal of Surgical Education
- Vol. 72 (6) , 1233-1239
Residents’ Experience in Breast Cancer Care
- 1 March 2013
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 85 (3) , 707-713
Discordance Between Preoperative and Postoperative Bladder Cancer Location: Implications for Partial-Bladder Radiation
- 1 March 2013
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 85 (3) , 707-713
Discordance Between Preoperative and Postoperative Bladder Cancer Location: Implications for Partial-Bladder Radiation